Evolution of Treatment in Advanced Cholangiocarcinoma: Old and New towards Precision Oncology

Evolution of Treatment in Advanced Cholangiocarcinoma: Old and New towards Precision Oncology

Cholangiocarcinoma (CCA) is a malignant neoplasm arising in the epithelium of the biliary tract. It represents the second most common primary liver cancer in the world, after hepatocellular carcinoma, and it constitutes 10–15% of hepatobiliary neoplasms and 3% of all gastrointestinal tumors. As in o...

Full description

Bibliographic Details
Main Authors: Maurizio Capuozzo, Mariachiara Santorsola, Loris Landi, Vincenza Granata, Francesco Perri, Venere Celotto, Oreste Gualillo, Guglielmo Nasti, Alessandro Ottaiano
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:International Journal of Molecular Sciences
Subjects:
cholangiocarcinoma
ivosidenib
pemigatinib
target therapy
genetics
precision oncology
Online Access:https://www.mdpi.com/1422-0067/23/23/15124

Similar Items

Similar Items